Star Health Sets Q2 FY27 Earnings Call for October 28

Earnings call scheduled for October 28

Star Health and Allied Insurance Company Limited has informed the stock exchanges that it will conduct its Q2 and H1 FY2027 earnings call on October 28, 2026. The intimation was filed under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations. The disclosure was made to BSE on October 16 at 4:45 pm. The call is expected to cover the insurer's financial performance for the quarter and half year ended September 30, 2026. It will follow the company's scheduled board meeting on October 27. The board is set to consider and approve unaudited financial results for the September quarter and first half of FY27.

Board meeting comes a day earlier

Star Health had informed exchanges on September 25 that its board would meet on October 27, 2026. The stated agenda is the declaration of unaudited financial results for Q2 and H1 FY2027. The earnings call scheduled for the following day provides investors a planned forum to hear management's discussion after the results process. The exchange filing does not provide Q2 financial figures or management commentary. As a result, the October 28 call is significant mainly as a confirmed corporate-calendar event. Investors will await the board-approved results and related disclosures for updated operating and financial information.

Q1 FY27 sets the recent performance base

The upcoming discussion follows a stronger first quarter for Star Health. Gross written premium, or GWP, rose 19% year-on-year to ₹4,287 crore in Q1 FY27. The company had reported GWP of ₹3,605 crore in the corresponding quarter of FY26. Insurance revenue grew 13% year-on-year to ₹4,917 crore. These figures provide the latest reported base against which the market may assess the September-quarter update.

Profitability improved in the June quarter

Star Health reported profit after tax of ₹550 crore for Q1 FY27, a 25% increase from the prior-year quarter. The company also reported normalised profit after tax of ₹386 crore at an 8% yield, up 44% year-on-year. Annualised return on equity was stated at 15.6%. Underwriting profit increased to ₹111 crore from ₹16 crore a year earlier. The improvement in underwriting profit was a key feature of the June-quarter update because it reflected a substantial change in core insurance operations.

Retail and digital channels were key growth areas

Fresh retail GWP increased 37% year-on-year to ₹730 crore in Q1 FY27. Star Health attributed this expansion to proprietary channels and digital direct-to-consumer activity. The company had also indicated that digital channels were expanding rapidly. Retail health insurance acquisition and distribution remain important operating areas for standalone health insurers. The Q2 and H1 call may provide further details on whether these channels continued to support premium growth, subject to management's disclosures.

Key reported Q1 FY27 metrics

FY27 growth outlook already communicated

In its latest conference-call update, Star Health projected insurance revenue growth of 15% to 16% for FY27. This is the company's disclosed outlook, rather than a market forecast. The Q2 results and investor interaction will be relevant for tracking performance against that stated range. No update to the annual guidance has been included in the October 16 earnings-call intimation. Any revision, reaffirmation or additional operating target would need to come through the company's subsequent results materials or management communication.

Regulation 30 disclosure framework

Regulation 30 requires listed companies to disclose material events and information to stock exchanges. An analyst or investor meeting schedule is one such disclosure category. Star Health's filing allows shareholders and other market participants to note the timing of its earnings engagement. The filing itself is an intimation of the event and not a release of financial results. Investors should distinguish the call schedule from the formal financial statements expected to be considered by the board on October 27.

What investors will track after the results

The Q2 release will update the market on premium growth, insurance revenue and profitability for the three months ended September 30. It will also provide the first consolidated view of performance across the first half of FY27. Given the Q1 improvement, underwriting performance and retail premium trends are likely to remain relevant reported metrics. The company has not disclosed Q2 numbers in the call-schedule announcement. Therefore, conclusions on the September quarter should wait for the board-approved results and accompanying investor materials.

Next steps in Star Health's result calendar

Star Health's board meeting is scheduled for October 27, 2026, to consider the unaudited Q2 and H1 FY27 results. Its earnings call is scheduled for October 28, 2026. The company previously released the audio recording of its Q1 FY27 earnings call on July 30, with access shared through BSE and NSE. The next official updates are expected through the results announcement, investor presentation and earnings-call communication. These disclosures will provide the factual basis for assessing the insurer's progress during the first half of FY27.